Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors
about
Pain genesCatechol-O-methyltransferase inhibition alters pain and anxiety-related volitional behaviors through activation of β-adrenergic receptors in the ratComt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of miceThe val158met polymorphism of human catechol-O-methyltransferase (COMT) affects anterior cingulate cortex activation in response to painful laser stimulation.Dysregulation of the autonomous nervous system in patients with temporomandibular disorder: a pupillometric study.Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs.Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of lifePathophysiology of fibromyalgia.The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions.Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesiaIn search of analgesia: emerging roles of GPCRs in pain.Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part I).β2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokinesEffect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study.A hotspot of inactivation: The A22S and V108M polymorphisms individually destabilize the active site structure of catechol O-methyltransferase.Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control studyGenetics of pain perception, COMT and postoperative pain management in children.Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision.Pharmacogenomic considerations in opioid analgesia.Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injuryGenetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome.The potential contribution of stress systems to the transition to chronic whiplash-associated disorders.Injury-Dependent and Disability-Specific Lumbar Spinal Gene Regulation following Sciatic Nerve Injury in the RatTranslating the human genome to manage pediatric postoperative pain.Molecular genetic mechanisms of allelic specific regulation of murine Comt expressionCOMT gene locus: new functional variantsCatechol-O-methyltransferase genotype predicts pain severity in hospitalized burn patients.COMT Diplotype Amplifies Effect of Stress on Risk of Temporomandibular Pain.Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism.Human pain and genetics: some basicsNuclear factor-kappa B regulates pain and COMT expression in a rodent model of inflammation.Serotonin-induced hypersensitivity via inhibition of catechol O-methyltransferase activityAdding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured WorkersModification of COMT-dependent pain sensitivity by psychological stress and sex.Biopsychosocial influence on shoulder pain: risk subgroups translated across preclinical and clinical prospective cohorts.Chronic pain after lower abdominal surgery: do catechol-O-methyl transferase/opioid receptor μ-1 polymorphisms contribute?Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized painPharmacogenetics of chronic pain and its treatment.Janus molecule I: dichotomous effects of COMT in neuropathic vs nociceptive pain modalities.
P2860
Q28473018-6BF74A21-1DB7-4177-B2BC-A93D35A517C5Q30386865-D7C0E559-AEC3-41C1-9073-5F0422FCE134Q30497304-04AF163C-A5EA-4BB6-82B2-D8C9A14D780AQ30983993-F991CDC5-1C89-4196-B217-0FEF0DB4C0A2Q31101668-F480D61D-8888-4F88-9745-0D1C2C8A1084Q33430005-334D2DE4-AD75-4ACC-BC15-03ED58AD0B87Q33569509-28184A31-CF78-4B88-A254-172E5EA72F0DQ33597755-254CD0D4-B396-4574-B106-D3B7A6EA445CQ33652567-EDAB4D75-4E3B-46D3-9A81-331962D1F665Q33685195-04E7EAD0-E0D1-40C1-8937-45F255630BF2Q33754272-7132316F-E315-4F82-A2F5-DF28D92EA2E0Q33819256-A587AD01-3803-434F-A045-67ECF016B1B4Q33843306-6CC3F6B4-2E49-4122-A7DC-71CDB0BF0BFAQ33863868-B3A69D13-2FCB-454E-B09D-4A8E00532B34Q33877710-E1C3E5AA-4E48-4A67-A456-0092A1A4ABD7Q34005767-5C708308-D2CA-4955-A7E3-43ADDFF72180Q34072368-C81F717C-5DB8-460B-979D-CA7D63D3E60FQ34117091-C91ED530-224D-4719-AB1E-19BC1A0F9134Q34284528-4167DF14-337F-4E0C-A1A5-1A81593336F2Q34316700-F6C95EB1-76C4-4252-A632-D37555262AE7Q34663695-DEEE510E-01C1-464D-BC8A-A5D6D2213394Q35431288-ACEBDDAC-36EA-4B7B-B843-1415E6FBE41BQ35597060-F86816CF-8243-4A69-9F80-1BBA3E931E1CQ35612565-E0A93BA9-727D-48BD-9C36-43A78E28B4B2Q35654256-67F83032-DC5A-4539-A98D-44DA32122C94Q35661564-65EDF395-92DC-4ADE-905E-547AF07960EDQ35710613-E6010772-A8CD-4889-AE12-ECFCBCC0E67BQ35871001-9D8EEFA9-C609-4F97-AA52-ED4C352CA0B4Q35990107-74903D64-ED06-40B5-A78E-4B64D716DB16Q35991170-F58EC57E-FB81-4293-B021-62656E468B57Q36110585-97483F40-0E80-460E-A6D7-F92346A2DE50Q36244796-E7D77EE2-CAC0-4F0F-96D0-C5526F157BF7Q36391713-AA0A96AA-1FF8-4834-B2C7-6280B660F27EQ36424264-ADC0BE44-1A96-4BDC-8CC1-9122841718D1Q36693066-2875E8E3-EE55-4DB5-BA88-759683BC8CE6Q36710202-0C179A32-B11E-4D31-97AA-EF22369ED7E1Q36758923-34311B4C-FD87-4325-8B9C-C3EB1AB3FD4CQ36842250-DB9ABA19-EB29-463B-8437-FD9947B552EEQ36900075-AD4E5D4B-45B6-4A12-A19D-49EE2723D2FDQ36972453-D5C09024-7765-46E9-9D04-182EF0A626AD
P2860
Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors
description
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im November 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/04/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/04/01)
@nl
наукова стаття, опублікована у квітні 2007
@uk
مقالة علمية (نشرت في أبريل 2007)
@ar
name
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@ast
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@en
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@nl
type
label
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@ast
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@en
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@nl
prefLabel
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@ast
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@en
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@nl
P2093
P2860
P1433
P1476
Catechol-O-methyltransferase i ...... and beta3-adrenergic receptors
@en
P2093
Andrea Gail Nackley
Karamarie Fecho
Luda Diatchenko
Patrick Flood
William Maixner
P2860
P304
P356
10.1016/J.PAIN.2006.09.022
P407
P50
P577
2006-11-07T00:00:00Z